At the end of Q4 2024, 26 institutions reported holding Phoenix Biotech Acq -CW26 (CEROW) in their 13F filings, down 4 from Q3 2024. 0 opened new positions and 3 sold out. The largest holders were Cantor Fitzgerald, L. P. ($4K), MMCAP International Inc. SPC ($3K) and Saba Capital Management, L.P. ($3K).
Company
Phoenix Biotech Acq -CW26
Filed as
CERO THERAPEUTICS HLDGS INC (Q4 2024)
CUSIP
71902K113
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
Institutions
Total Value
New Positions
0
$0
Exits
3
$803
All 13F filers, Q3 2024 → Q4 2024: 326,636 shares sold, net −326,636 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.